Loading organizations...
Loading organizations...
Cell-generated immunotherapies for eradicating solid tumors.
AvengeBio has raised $45.0M across 1 funding round.
AvengeBio has raised $45.0M in total across 1 funding round.
AvengeBio has raised $45.0M in total across 1 funding round.
AvengeBio's investors include Ben Askew, CAM Capital, Perceptive Xontogeny Venture Fund, Josh Richardson, Pappas Capital, Rock Springs Capital.
AvengeBio has raised $45.0M across 1 funding round. Most recently, it raised $45.0M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 10, 2022 | $45.0M Series A | Ben Askew, CAM Capital, Perceptive Xontogeny Venture Fund | Josh Richardson, Pappas Capital, Rock Springs Capital |